These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1327 related articles for article (PubMed ID: 31941785)

  • 1. Phase Separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP Controls Gene Expression.
    Peng Q; Wang L; Qin Z; Wang J; Zheng X; Wei L; Zhang X; Zhang X; Liu C; Li Z; Wu Y; Li G; Yan Q; Ma J
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Nuclear Antigen Leader Protein Coactivates EP300.
    Wang C; Zhou H; Xue Y; Liang J; Narita Y; Gerdt C; Zheng AY; Jiang R; Trudeau S; Peng CW; Gewurz BE; Zhao B
    J Virol; 2018 May; 92(9):. PubMed ID: 29467311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2.
    Peng CW; Zhao B; Chen HC; Chou ML; Lai CY; Lin SZ; Hsu HY; Kieff E
    Blood; 2007 Jun; 109(12):5447-54. PubMed ID: 17341665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
    Portal D; Zhao B; Calderwood MA; Sommermann T; Johannsen E; Kieff E
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7808-13. PubMed ID: 21518914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four EBNA2 domains are important for EBNALP coactivation.
    Peng CW; Zhao B; Kieff E
    J Virol; 2004 Oct; 78(20):11439-42. PubMed ID: 15452270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional expression of a dominant-negative form of Epstein-Barr virus (EBV) nuclear antigen EBNALP inhibits EBV-positive lymphoblastoid cell growth.
    Harada S; Saijo M
    Arch Virol; 2020 Feb; 165(2):313-320. PubMed ID: 31813023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells.
    Liu CD; Chen YL; Min YL; Zhao B; Cheng CP; Kang MS; Chiu SJ; Kieff E; Peng CW
    PLoS Pathog; 2012; 8(12):e1003084. PubMed ID: 23271972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes.
    Schmidt SC; Jiang S; Zhou H; Willox B; Holthaus AM; Kharchenko PV; Johannsen EC; Kieff E; Zhao B
    Proc Natl Acad Sci U S A; 2015 Jan; 112(2):554-9. PubMed ID: 25540416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.
    Peng CW; Xue Y; Zhao B; Johannsen E; Kieff E; Harada S
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1033-8. PubMed ID: 14732686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites.
    Wang A; Welch R; Zhao B; Ta T; Keleş S; Johannsen E
    J Virol; 2015 Dec; 90(6):2906-19. PubMed ID: 26719268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.
    Schlee M; Krug T; Gires O; Zeidler R; Hammerschmidt W; Mailhammer R; Laux G; Sauer G; Lovric J; Bornkamm GW
    J Virol; 2004 Apr; 78(8):3941-52. PubMed ID: 15047810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.
    Portal D; Rosendorff A; Kieff E
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19278-83. PubMed ID: 17159145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
    Gross H; Hennard C; Masouris I; Cassel C; Barth S; Stober-Grässer U; Mamiani A; Moritz B; Ostareck D; Ostareck-Lederer A; Neuenkirchen N; Fischer U; Deng W; Leonhardt H; Noessner E; Kremmer E; Grässer FA
    PLoS One; 2012; 7(8):e42106. PubMed ID: 22879910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus-infected B cells.
    Beer S; Wange LE; Zhang X; Kuklik-Roos C; Enard W; Hammerschmidt W; Scialdone A; Kempkes B
    Proc Natl Acad Sci U S A; 2022 Jul; 119(30):e2200512119. PubMed ID: 35857872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.
    Hosoi H; Niibori-Nambu A; Nah GSS; Bahirvani AG; Mok MMH; Sanda T; Kumar AP; Tenen DG; Ito Y; Sonoki T; Osato M
    Gene; 2021 Mar; 774():145421. PubMed ID: 33444684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R; Moses SC; Tan J; Kremmer E; Ling PD
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional characterization of a complex between the acidic transactivation domain of EBNA2 and the Tfb1/p62 subunit of TFIIH.
    Chabot PR; Raiola L; Lussier-Price M; Morse T; Arseneault G; Archambault J; Omichinski JG
    PLoS Pathog; 2014 Mar; 10(3):e1004042. PubMed ID: 24675874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
    Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
    Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase separation of Epstein-Barr virus EBNA2 protein reorganizes chromatin topology for epigenetic regulation.
    Yang Y; Ye X; Dai R; Li Z; Zhang Y; Xue W; Zhu Y; Feng D; Qin L; Wang X; Lei B; Liao S; Hao B
    Commun Biol; 2021 Aug; 4(1):967. PubMed ID: 34400762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.